Levodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra

Mov Disord. 2005 Feb;20(2):258-60. doi: 10.1002/mds.20323.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use
  • Brain Injuries / complications*
  • Female
  • Humans
  • Iodine Radioisotopes / pharmacokinetics
  • Levodopa / adverse effects
  • Levodopa / therapeutic use
  • Magnetic Resonance Imaging / methods
  • Middle Aged
  • Parkinson Disease, Secondary / diagnostic imaging*
  • Parkinson Disease, Secondary / drug therapy
  • Substantia Nigra / diagnostic imaging*
  • Substantia Nigra / pathology
  • Tomography, Emission-Computed, Single-Photon / methods
  • Tropanes / pharmacokinetics

Substances

  • Antiparkinson Agents
  • Iodine Radioisotopes
  • Tropanes
  • 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
  • Levodopa